Chemokine Expression in Nummular Dermatitis and Atopic Dermatitis
NCT01311986 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2011-04-22
Summary
The aim of this study is to measure the serum levels of CCL17, CCL18, CCL22 and CXCL10 and their expression levels in epidermis in AD and ND patients.
Conditions
- Atopic Dermatitis
- Nummular Eczema
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Hsien-Ching Chiu, MD · Department of Dermatology, National Taiwan University Hospital
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2011-10-31
- Completion
- 2012-03-31
Countries
- Taiwan
More Related Trials
-
Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis
NCT05059509 ·Status: COMPLETED ·Phase: PHASE2
-
The Study of CM326 in Adult Subjects With Atopic Dermatitis
NCT05671445 ·Status: UNKNOWN ·Phase: PHASE2
-
The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis
NCT05186922 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
NCT01756898 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials
NCT06174493 ·Status: NOT_YET_RECRUITING
-
Vitamin D Treatment Effect for Atopic Dermatitis in Children
NCT05523986 ·Status: UNKNOWN ·Phase: NA
-
Establishing the Collaborative Care Model of Traditional Chinese Medicine and Western Medicine-Pediatric Atopic Dermatitis
NCT03375970 ·Status: UNKNOWN ·Phase: NA
-
China Atopic Dermatitis Registry Study
NCT05023668 ·Status: UNKNOWN
-
Atopic Dermatitis (AD) and Food Allergy
NCT03168113 ·Status: COMPLETED
-
A Trial of Antroquinonol in Patients With Atopic Dermatitis
NCT03622463 ·Status: COMPLETED ·Phase: PHASE2
-
Dynamic Blood Inflammatory Profile in Atopic Dermatitis Patients (ADAMUNE)
NCT05868824 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Molecular Signatures of Cutaneous Dupilumab Response
NCT05858619 ·Status: RECRUITING ·Phase: PHASE4
-
Study of CM310 in Adolescent Subjects With Atopic Dermatis
NCT06495229 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Dupilumab in Severe Chronic Hand Eczema
NCT04512339 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis (AD) Through Chart Review
NCT06503536 ·Status: COMPLETED
-
Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel
NCT05253755 ·Status: TERMINATED ·Phase: PHASE2
-
Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
NCT03361215 ·Status: RECRUITING
-
Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)
NCT06353087 ·Status: RECRUITING
-
A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.
NCT04836858 ·Status: COMPLETED ·Phase: PHASE2
-
Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals
NCT00001760 ·Status: COMPLETED
-
Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage
NCT01179529 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis
NCT05579925 ·Status: COMPLETED ·Phase: PHASE2
-
Herbal Ointment in Treating Atopic Dermatitis Topically
NCT06850311 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism
NCT04455906 ·Status: RECRUITING
-
Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis
NCT06553209 ·Status: COMPLETED ·Phase: PHASE1